Concepedia

Publication | Closed Access

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

DOI

141

Citations

24

References

2003

Year

Wen-Jen Hwu, Susan E. Krown, Jennifer H. Menell, Katherine S. Panageas, Janene Merrell, Lynne Lamb, Linda Williams, Carolyn Quinn, Theresa Foster, Paul B. Chapman,
Journal of Clinical Oncology

Abstract

The combination of temozolomide plus thalidomide seems to be a promising and well-tolerated oral regimen for metastatic melanoma that merits further study.

References

YearCitations

Page 1